Skip to main content
BBNX
NASDAQ Life Sciences

Beta Bionics Q2 Sales Jump 38%, Raises Gross Margin Outlook

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$15.61
Mkt Cap
$676.001M
52W Low
$8.8
52W High
$32.71
52W Position info
77% above low
Off High info
52% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

BBNX sits 77% above its 52-week low of $8.8.

Summary

Beta Bionics delivered strong Q2 results with net sales of $32.0 million, a 38% increase year-over-year, driven by a 153% surge in the higher-margin pharmacy channel. Gross margin expanded 524 basis points to 59.0%, and the company raised its full-year gross margin guidance to 58.5%-59.5%. New patient starts grew 10-20% sequentially, with nearly 70% coming from multiple daily injections, signaling market share gains. The company also initiated a pivotal trial for its iLet system in type 2 diabetes, targeting a mid-2027 label expansion, and updated its Mint patch pump commercialization timeline to end of Q2 2027. With $225.2 million in cash, the runway extends well beyond these milestones. The raised margin outlook and pipeline progress reinforce the growth narrative, though operating losses remain substantial at $25.6 million.

Updates

  1. · SEC 10-Q — 10-Q shows cash and investments of $225.1M at June 30, 2026, net loss of $23.4M for Q2, and 44,981,606 shares outstanding.

At the time of this announcement, BBNX was trading at $15.61 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $676M. The 52-week trading range was $8.80 to $32.71. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

BBNX - Latest Insights

BBNX
Oct 27, 2026, 4:20 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $18.92
Real-time Price: $13.98 info
Change: -$4.94 (-26%) info
Market Cap: $757.877M info
BBNX
Oct 27, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $20.89
Real-time Price: $13.98 info
Change: -$6.91 (-33%) info
Market Cap: $757.877M info
BBNX
Oct 27, 2026, 4:02 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $21.01
Real-time Price: $13.98 info
Change: -$7.03 (-33%) info
Market Cap: $757.877M info
BBNX
Oct 06, 2026, 5:36 AM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $18.95
Real-time Price: $13.98 info
Change: -$4.97 (-26%) info
Market Cap: $757.877M info
BBNX
Sep 22, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $22.19
Real-time Price: $13.98 info
Change: -$8.21 (-37%) info
Market Cap: $757.877M info